Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Requests Withdrawal Of Makena And Generics
Hydroxyprogesterone Withdrawal Request Goes Beyond Failed Confirmatory Trial
Oct 08 2020
•
By
Sue Sutter
US FDA is pursuing withdrawal so as not to damage the integrity of the accelerated approval pathway • Source: Shutterstock
More from Generics
More from Products